- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/58 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving labelled substances
Patent holdings for IPC class G01N 33/58
Total number of patents in this class: 6552
10-year publication summary
438
|
523
|
571
|
468
|
517
|
502
|
523
|
535
|
523
|
278
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19887 |
106 |
Life Technologies Corporation | 3290 |
85 |
Ventana Medical Systems, Inc. | 1021 |
84 |
Becton, Dickinson and Company | 7254 |
79 |
Promega Corporation | 571 |
66 |
Centre National de La Recherche Scientifique | 10418 |
60 |
Massachusetts Institute of Technology | 10041 |
60 |
F. Hoffmann-La Roche AG | 7930 |
51 |
10X Genomics, Inc. | 1202 |
46 |
Bio-Rad Laboratories, Inc. | 1615 |
42 |
Siemens Healthcare Diagnostics Inc. | 2043 |
41 |
President and Fellows of Harvard College | 5972 |
40 |
The Board of Trustees of the Leland Stanford Junior University | 6403 |
39 |
Board of Regents, The University of Texas System | 5782 |
39 |
The General Hospital Corporation | 4724 |
36 |
Purdue Research Foundation | 3593 |
36 |
Sony Group Corporation | 13751 |
35 |
Roche Diagnostics Operations, Inc. | 1486 |
34 |
The Johns Hopkins University | 5662 |
31 |
Agilent Technologies, Inc. | 2638 |
30 |
Other owners | 5512 |